Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy.
Vazhappilly CG, Siddiqui SS, Anto RJ, Radhakrishnan R, Devanga Ragupathi NK. Vazhappilly CG, et al. Among authors: anto rj. Front Pharmacol. 2023 Nov 7;14:1320139. doi: 10.3389/fphar.2023.1320139. eCollection 2023. Front Pharmacol. 2023. PMID: 38027035 Free PMC article. No abstract available.
Cancer Chemoprevention: A Strategic Approach Using Phytochemicals.
G MS, Swetha M, Keerthana CK, Rayginia TP, Anto RJ. G MS, et al. Among authors: anto rj. Front Pharmacol. 2022 Jan 13;12:809308. doi: 10.3389/fphar.2021.809308. eCollection 2021. Front Pharmacol. 2022. PMID: 35095521 Free PMC article. Review.
Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers.
Pouliquen DL, Gall Trošelj K, Anto RJ, Naidu R. Pouliquen DL, et al. Among authors: anto rj. Front Pharmacol. 2023 Aug 18;14:1266793. doi: 10.3389/fphar.2023.1266793. eCollection 2023. Front Pharmacol. 2023. PMID: 37675041 Free PMC article. No abstract available.
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: anto rj. Front Oncol. 2023 Dec 15;13:1302413. doi: 10.3389/fonc.2023.1302413. eCollection 2023. Front Oncol. 2023. PMID: 38162481 Free PMC article.
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma.
Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N, Anto RJ. Nath LR, et al. Among authors: anto rj. Front Oncol. 2022 Feb 8;12:812598. doi: 10.3389/fonc.2022.812598. eCollection 2022. Front Oncol. 2022. PMID: 35211405 Free PMC article.
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.
Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N, Anto RJ. Nath LR, et al. Among authors: anto rj. Front Oncol. 2022 Aug 25;12:991401. doi: 10.3389/fonc.2022.991401. eCollection 2022. Front Oncol. 2022. PMID: 36091117 Free PMC article.
64 results